Cargando…

Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function

Macrophage is an important innate immune cell that not only initiates inflammatory responses, but also functions in tissue repair and anti-inflammatory responses. Regulating macrophage activity is thus critical to maintain immune homeostasis. Tyro3, Axl, and Mer are integral membrane proteins that c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chang-Hee, Chun, Taehoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2019
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354059/ https://www.ncbi.nlm.nih.gov/pubmed/30699285 http://dx.doi.org/10.14348/molcells.2018.0419

Ejemplares similares

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
por: Jiménez-García, Lidia, et al.
Publicado: (2022)

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
por: Abunada, Aya, et al.
Publicado: (2023)

Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis
por: Lan, Chou-Chin, et al.
Publicado: (2022)

Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer
por: Happonen, Kaisa E., et al.
Publicado: (2023)

Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
por: Lemos, C, et al.
Publicado: (2008)

Current understanding of the role of tyrosine kinase 2 signaling in immune responses
por: Muromoto, Ryuta, et al.
Publicado: (2022)

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
por: Stuckey, Ruth, et al.
Publicado: (2020)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase
por: Kimani, Stanley G., et al.
Publicado: (2016)

The Role of Macrophage Polarization in Infectious and Inflammatory Diseases
por: Labonte, Adam C., et al.
Publicado: (2014)

Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
por: Lashgari, Naser-Aldin, et al.
Publicado: (2021)

Bioengineering of Anti‐Inflammatory Natural Products
por: Winand, Lea, et al.
Publicado: (2020)

Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017)

The olfactory receptor family album
por: Crasto, Chiquito, et al.
Publicado: (2001)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis
por: Zhou, Yandan, et al.
Publicado: (2023)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
por: Pirola, Luciano, et al.
Publicado: (2017)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
por: Crispino, Federica, et al.
Publicado: (2023)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
por: Lee, Eunju, et al.
Publicado: (2021)

Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Tale of two kinases: Protein kinase A and Ca(2+)/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy
por: Gaitán-González, Pamela, et al.
Publicado: (2021)

Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation
por: Xiao, Shuiming, et al.
Publicado: (2014)

Development and Functions of Alveolar Macrophages
por: Woo, Yeon Duk, et al.
Publicado: (2021)

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
por: Muimo, Richmond, et al.
Publicado: (2006)

Molecular typing of familial temporal lobe epilepsy
por: Liu, Chao, et al.
Publicado: (2022)

Evolution of the Translocation and Assembly Module (TAM)
por: Heinz, Eva, et al.
Publicado: (2015)

Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling
por: Chaudhuri, Amitabha
Publicado: (2014)

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
por: Peña-Asensio, Julia, et al.
Publicado: (2020)

Caspase Cleavage of Receptor Tyrosine Kinases in the Dependence Receptor Family
por: Park, Gyu Hwan, et al.
Publicado: (2023)

TAMeless traitors: macrophages in cancer progression and metastasis
por: Aras, Shweta, et al.
Publicado: (2017)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
por: Hellemans, R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nkennld6oobk7in98k5f150ur3